SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular Carcinoma
Clinical trial NCT04913480 · UNKNOWN
Trial details
- NCT number
- NCT04913480
- Sponsor
- The University of Hong Kong
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-15
- Primary completion
- 2023-12-31
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.